Inhibrx Biosciences, Inc. Quarterly Operating Lease, Liability in USD from Q4 2023 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Present value of lessee's discounted obligation for lease payments from operating lease.
Summary: Inhibrx Biosciences, Inc. quarterly Operating Lease, Liability history and growth rate from Q4 2023 to Q2 2025.
Inhibrx Biosciences, Inc. Operating Lease, Liability for the quarter ending June 30, 2025 was $7.51M, a 246% increase year-over-year.

Operating Lease, Liability, Quarterly (USD)

Operating Lease, Liability, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$7.51M	+$5.34M	+246%	Jun 30, 2025	10-Q	2025-08-13
Q1 2025	$7.88M			Mar 31, 2025	10-Q	2025-05-14
Q4 2024	$8.05M	+$4.88M	+154%	Dec 31, 2024	10-Q	2025-08-13
Q3 2024	$1.84M			Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$2.17M			Jun 30, 2024	10-Q	2024-08-13
Q4 2023	$3.17M			Dec 31, 2023	10-K	2025-03-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.